Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pancreatic Neuroendocrine Tumors
Leonardo P. Marcal, Hubert H. Chuang, Hop S. Tran Cao, et al.
Elsevier eBooks (2022), pp. 197-217
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Non-functional neuroendocrine tumors of the pancreas: Advances in diagnosis and management
Jordan M. Cloyd
World Journal of Gastroenterology (2015) Vol. 21, Iss. 32, pp. 9512-9512
Open Access | Times Cited: 112
Resection of primary tumor site is associated with prolonged survival in metastatic nonfunctioning pancreatic neuroendocrine tumors
Xavier M. Keutgen, Naris Nilubol, Joanne Glanville, et al.
Surgery (2015) Vol. 159, Iss. 1, pp. 311-319
Open Access | Times Cited: 107
Identification of tumorigenic cells and therapeutic targets in pancreatic neuroendocrine tumors
Geoffrey W. Krampitz, Benson M. George, Stephen B. Willingham, et al.
Proceedings of the National Academy of Sciences (2016) Vol. 113, Iss. 16, pp. 4464-4469
Open Access | Times Cited: 82
A Clinicopathologic and Molecular Update of Pancreatic Neuroendocrine Neoplasms With a Focus on the New World Health Organization Classification
Jiayun M. Fang, Jiaqi Shi
Archives of Pathology & Laboratory Medicine (2019) Vol. 143, Iss. 11, pp. 1317-1326
Open Access | Times Cited: 63
Malignant-functioning neuroendocrine tumors of the pancreas: A survival analysis
Xavier M. Keutgen, Naris Nilubol, Electron Kebebew
Surgery (2015) Vol. 159, Iss. 5, pp. 1382-1389
Closed Access | Times Cited: 50
Pancreatic neuroendocrine tumors
Giampaolo Perri, Laura R. Prakash, Matthew H. G. Katz
Current Opinion in Gastroenterology (2019) Vol. 35, Iss. 5, pp. 468-477
Closed Access | Times Cited: 44
CD47 expression and CD163+ macrophages correlated with prognosis of pancreatic neuroendocrine tumor
Rami Imam, Qing Chang, Margaret A. Black, et al.
BMC Cancer (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 25
Assessment of the American Joint Commission on Cancer 8th Edition Staging System for Patients with Pancreatic Neuroendocrine Tumors: A Surveillance, Epidemiology, and End Results analysis
Xiaogang Li, Shanmiao Gou, Zhiqiang Liu, et al.
Cancer Medicine (2018) Vol. 7, Iss. 3, pp. 626-634
Open Access | Times Cited: 30
Palliative Resection of Primary Tumor in Metastatic Nonfunctioning Pancreatic Neuroendocrine Tumors
Hua Ye, Hong Liu Xu, Qijun Shen, et al.
Journal of Surgical Research (2019) Vol. 243, pp. 578-587
Closed Access | Times Cited: 28
Update on the Surgical Treatment of Pancreatic Neuroendocrine Tumors
Florence Le Jeune, Abdelkader Taïbi, Sébastien Gaujoux
Scandinavian Journal of Surgery (2020) Vol. 109, Iss. 1, pp. 42-52
Open Access | Times Cited: 25
Strong antitumor efficacy of a pancreatic tumor‐targeting oncolytic adenovirus for neuroendocrine tumors
Yuki Yamamoto, Masaki Nagasato, Yosei Rin, et al.
Cancer Medicine (2017) Vol. 6, Iss. 10, pp. 2385-2397
Open Access | Times Cited: 28
Differentiation of solid-pseudopapillary tumors of the pancreas from pancreatic neuroendocrine tumors by using endoscopic ultrasound
Yuan Liu, Si Shi, Jie Hua, et al.
Clinics and Research in Hepatology and Gastroenterology (2020) Vol. 44, Iss. 6, pp. 947-953
Closed Access | Times Cited: 21
Diagnostic Differentiation of Pancreatic Neuroendocrine Tumor From Other Neoplastic Solid Pancreatic Lesions During Endoscopic Ultrasound-Guided Fine-Needle Aspiration
Somashekar G. Krishna, Abhik Bhattacharya, Feng Li, et al.
Pancreas (2015) Vol. 45, Iss. 3, pp. 394-400
Closed Access | Times Cited: 24
Novel Dual-Action Targeted Nanomedicine in Mice With Metastatic Thyroid Cancer and Pancreatic Neuroendocrine Tumors
Naris Nilubol, Ziqiang Yuan, Giulio F. Paciotti, et al.
JNCI Journal of the National Cancer Institute (2018) Vol. 110, Iss. 9, pp. 1019-1029
Open Access | Times Cited: 21
Prognostic Validity of the American Joint Committee on Cancer Eighth Edition TNM Staging System for Surgically Treated and Well-Differentiated Pancreatic Neuroendocrine Tumors
Min Yang, Yi Zhang, Lin Zeng, et al.
Pancreas (2019) Vol. 48, Iss. 5, pp. 613-621
Closed Access | Times Cited: 18
PPoma Review: Epidemiology, Aetiopathogenesis, Prognosis and Treatment
Thaís Gleice Martins Braga, Ralph Santos‐Oliveira
Diseases (2018) Vol. 6, Iss. 1, pp. 8-8
Open Access | Times Cited: 18
Modelling Pancreatic Neuroendocrine Cancer: From Bench Side to Clinic
Alexander Ney, Gabriele Canciani, J. Justin Hsuan, et al.
Cancers (2020) Vol. 12, Iss. 11, pp. 3170-3170
Open Access | Times Cited: 16
Genetic polymorphisms of inflammatory response gene TNF-α and its influence on sporadic pancreatic neuroendocrine tumors predisposition risk
Dimitriοs Karakaxas, Maria Gazouli, Ahmet Çöker, et al.
Medical Oncology (2014) Vol. 31, Iss. 10
Closed Access | Times Cited: 13
Incidence and management of postoperative hyperglycemia in patients undergoing insulinoma resection
Pavel Nockel, Amit Tirosh, Mustapha El Lakis, et al.
Endocrine (2018) Vol. 61, Iss. 3, pp. 422-427
Open Access | Times Cited: 13
Hypoglycemia and decreased insulin requirement caused by malignant insulinoma in a type 1 diabetic patient: when the hoof beats are from a zebra, not a horse
Hilde Kollsete Gjelberg, Dag Hoem, Caroline S. Verbeke, et al.
Clinical Case Reports (2017) Vol. 5, Iss. 6, pp. 761-768
Open Access | Times Cited: 12
Usefulness of the octreotide test in Japanese patients for predicting the presence/absence of somatostatin receptor 2 expression in insulinomas
Akinobu Nakamura, Tomoko Mitsuhashi, Yoshinari Takano, et al.
Endocrine Journal (2015) Vol. 63, Iss. 2, pp. 135-142
Open Access | Times Cited: 10
Differentiation between non-hypervascular pancreatic neuroendocrine tumors and mass-forming pancreatitis using contrast-enhanced computed tomography
Yajie Wang, Xin Chen, Jianhua Wang, et al.
Acta Radiologica (2020) Vol. 62, Iss. 2, pp. 190-197
Closed Access | Times Cited: 7
Association of a Palliative Surgical Approach to Stage IV Pancreatic Neuroendocrine Neoplasms with Survival: A Systematic Review and Meta-Analysis
Marina Tsoli, Maria-Eleni Spei, Göran Wallin, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2246-2246
Open Access | Times Cited: 6
Carcinoid Syndrome Complicating a Pancreatic Neuroendocrine Tumor
James N. Gerson, Ronald Witteles, Daniel T. Chang, et al.
Pancreas (2017) Vol. 46, Iss. 10, pp. 1381-1385
Closed Access | Times Cited: 5
New Horizons for Targeted Treatment of Neuroendocrine Tumors
Alberto Mangano, Georgios D. Lianos, Dimitrios H Roukos, et al.
Future Oncology (2016) Vol. 12, Iss. 8, pp. 1059-1065
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top